Cargando…
The Safety of Systemic Treatments That Can Be Used for Geriatric Psoriasis Patients: A Review
Background. Patients with moderate-to-severe psoriasis are often treated with systemic immunosuppressant agents that decrease immune system function. For the elderly, these medications are often problematic due to their already immunosuppressed state and comorbidities. However, there are few studies...
Autores principales: | Wong, Jillian W., Koo, John Y. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368172/ https://www.ncbi.nlm.nih.gov/pubmed/22685455 http://dx.doi.org/10.1155/2012/367475 |
Ejemplares similares
-
Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability
por: Abrouk, Michael, et al.
Publicado: (2016) -
Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik, Benjamin, et al.
Publicado: (2016) -
Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009) -
The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007) -
Systemic Treatment of Pediatric Psoriasis: A Review
por: Napolitano, Maddalena, et al.
Publicado: (2016)